MetLife Investment Management’s Absci ABSI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$199K Buy
66,490
+14,160
+27% +$41K ﹤0.01% 2230
2025
Q4
$183K Sell
52,330
-23,120
-31% -$84.3K ﹤0.01% 2322
2025
Q3
$229K Buy
75,450
+6,750
+10% +$18.7K ﹤0.01% 2241
2025
Q2
$177K Buy
68,700
+35,594
+108% +$100K ﹤0.01% 2259
2025
Q1
$83.1K Sell
33,106
-6,751
-17% -$24.8K ﹤0.01% 2600
2024
Q4
$104K Sell
39,857
-8,692
-18% -$30.6K ﹤0.01% 2604
2024
Q3
$185K Buy
48,549
+27,355
+129% +$109K ﹤0.01% 2326
2024
Q2
$65.3K Buy
+21,194
New +$98.3K ﹤0.01% 2720
2023
Q1
Sell
-34,080
Closed -$71.6K 2787
2022
Q4
$71.6K Hold
34,080
﹤0.01% 2699
2022
Q3
$107K Buy
34,080
+289
+0.9% +$1.06K ﹤0.01% 2656
2022
Q2
$112K Hold
33,791
﹤0.01% 2663
2022
Q1
$285K Buy
+33,791
New +$265K ﹤0.01% 2123

Other funds holding ABSI

MetLife Investment Management's ABSI Position: Q1 2026 in Review

MetLife Investment Management increased its Absci (ABSI) stake by 27% in Q1 2026, buying an estimated $41K and bringing the position to 66,490 shares worth $199K. The position accounts for ﹤0.01% of the portfolio, ranked #2230.

MetLife Investment Management first reported a position in ABSI in Q1 2022 and has held it in 12 quarters since. The position peaked at $285K in Q1 2022. 164 funds tracked by Wall St. Rank hold ABSI as of Q1 2026.

  • MetLife Investment Management held 66,490 shares of Absci worth $199K as of Q1 2026.
  • MetLife Investment Management bought 14,160 Absci shares in Q1 2026, an estimated $41K.
  • Absci made up ﹤0.01% of MetLife Investment Management's portfolio in Q1 2026, its #2230 holding.
  • MetLife Investment Management first reported a position in Absci in Q1 2022 and has held it in 12 quarters since.
  • MetLife Investment Management's Absci position peaked at $285K in Q1 2022.
  • 164 funds tracked by Wall St. Rank held Absci as of Q1 2026.

Based on MetLife Investment Management's 13F filing for Q1 2026, filed 14 May 2026.